Navigation Links
Amikacin Inhale Shows Promising Results in Phase II Study
Date:5/19/2008

cin Lung Deposition Correlates with in vitro Findings(5)

This study describes the in-vitro and in-vivo characterization of a handheld version of Amikacin Inhale, intended for use in extubated patients. In-vitro, amikacin 400 mg was aerosolized continuously, and emitted mass captured on absolute filters distal to the mouthpiece during simulated adult tidal breathing. Emitted mass was 87 percent of the 400 mg amikacin nominal dose, with a predicted lung dose of 45-50 percent. In-vivo, Amikacin Inhale (400 mg amikacin) labeled with 99mTc was administered to healthy subjects using the hand-held version. In these, mean amikacin lung dose determined via scintigraphy was 172.2 mg, 43 percent of the nominal dose. These results show that the hand-held drug-device combination delivered a large fraction of the starting dose, confirming the high delivery efficiency predicted by in-vitro aerosol characterization. The study also confirmed that the in-vitro model is predictive of the in-vivo experience. Lung doses in the range of those observed are expected to achieve bacteriological eradiation.

Copies of abstracts are available and can be viewed online at the ATS website: http://www.abstracts2view.com/ats08/

About Bayer HealthCare Pharmaceuticals Inc.

Bayer HealthCare Pharmaceuticals Inc. is the U.S.-based pharmaceuticals unit of Bayer HealthCare LLC, a division of Bayer AG. One of the world's leading, innovative companies in the healthcare and medical products industry, Bayer HealthCare combines the global activities of the Animal Health, Consumer Care, Diabetes Care, and Pharmaceuticals divisions. In the U.S., Bayer HealthCare Pharmaceuticals comprises the following business units: Diagnostic Imaging, General Medicine, Specialty Medicine and Women's Healthcare. The company's aim is to discover and manufacture products that will improve human health worldwide by diagnosing, preventing an
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
2. Inhaled Steriods Used as Preventive Treatment Post 9/11
3. Arriva Pharmaceuticals Moves Forward to Phase 2b Development of Lead Inhaled Protein rAAT Replacement Therapy for Hereditary Emphysema
4. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
5. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
6. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
7. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
8. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
9. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
10. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
11. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... KV Pharmaceutical Company ( KVa/KVb) ... received a written notice (the "Notice") executed by the ... of the Company, requesting that the Board of Directors ... for stockholder action by written consent relating to the ... director seat resulting from Ronald J. Kanterman,s departure (the ...
(Date:12/15/2009)... 15 SRI International, an independent nonprofit ... of U.S. patent 7,592,021 for a new bioadhesive ... drugs through the human body,s mucous membranes. This ... allows for a much longer release time compared ... Transmucosal delivery is an effective means to introduce ...
(Date:12/15/2009)... KNOXVILLE, Tenn., Dec. 15 Medical researchers ... attention with their revolutionary new technology for a ... ,, Following the success of its ... filed a patent on the biomarker, CA11-19, and ... inexpensive blood test, ColoMarker(TM) will detect colon cancer ...
Breaking Medicine Technology:KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 2KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 3KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 4KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 5KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 6KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 7SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 2SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 3SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 4SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 5Researchers Announce Medical Breakthrough with Simple, Inexpensive Blood Test for Colon Cancer 2Stanford study recommends change in treating pulmonary embolisms 60161 1Stanford study recommends change in treating pulmonary embolisms 60161 2Stanford study recommends change in treating pulmonary embolisms 60161 3Stanford study recommends change in treating pulmonary embolisms 60161 4Vegetables can protect unborn child against diabetes 10545 1Vegetables can protect unborn child against diabetes 10545 2Stanford researchers awarded 246 27 million to study energy efficiency and human behavior 10541 1Stanford researchers awarded 246 27 million to study energy efficiency and human behavior 10541 2
(Date:12/16/2009)... 16 Medizone International, Inc. (OTC Bulletin ... of Directors and the Board of Medizone New ... International Inc. holds a 50% interest, agreed on ... and reconvey to Medizone International all global marketing ... International,s Chairman, Edwin G. Marshall said, "Time has ...
(Date:12/16/2009)... Study finds 6- to 11-month interval lessens complication risks , , ... bundle of joy has had such a profound impact on ... take a breath. A new study suggests that you ... pregnant again, and that more than 11 months could be ... interval between pregnancies was less than six months, the chances ...
(Date:12/16/2009)... 16 /PRNewswire-FirstCall/ - TSO3 Inc. ("TSO3") (TSX: TOS) ... has been reached for 3M to be the ... Sterilizer. The partnership with TSO3, an innovator in ... healthcare settings through the use of ozone, will ... through 3M,s global sales channel. This agreement, combined ...
(Date:12/16/2009)... engaged in the development of products that help survivors of ... mobility, announces the publication of an interview with the inventors ... (Advance for Physical Therapy and Rehab Medicine, vol. 20, issue ... , ... (PRWEB) December 16, 2009 -- ...
(Date:12/16/2009)... of buying another product or thing for your loved ones this ... personal assistant services like housekeeping, errand running, child care, and pet ... ... December 12, 2009 -- Residents of the Denver and Boulder metro ... to their friends and loved ones by using Delegate Source,s " ...
Breaking Medicine News(10 mins):Health News:Medizone International, Inc. Approves Repurchase of Global Marketing Rights 2Health News:For Babies' Sake, Pregnancy Spacing Matters 2Health News:For Babies' Sake, Pregnancy Spacing Matters 3Health News:TSO3 and 3M agree to global channel partnership - 3M to begin rollout in sequential markets as regulatory clearances are received 2Health News:TSO3 and 3M agree to global channel partnership - 3M to begin rollout in sequential markets as regulatory clearances are received 3Health News:TSO3 and 3M agree to global channel partnership - 3M to begin rollout in sequential markets as regulatory clearances are received 4Health News:New Tailwind Device Improves Arm Function in Stroke Survivors with Paralysis 2Health News:Give the Gift of Service This Holiday Season with Delegate Source 2Health News:Give the Gift of Service This Holiday Season with Delegate Source 3
... emission tomography (PET) imaging with bioluminescencethe light produced by ... understand the behavior of transplanted or implanted stem cells ... treatments for disease. , According to a study ... found that using the unique combination of noninvasive PET ...
... 6 A Canadian research team led by ... Columbia, Vancouver has,determined that there are significant changes ... instead of a standard exercise bicycle.,This research offers ... date on,the positive health and fitness effects of ...
... Medicaid Generic Prescription,Drug System, FRANKFORT, Ky., Dec. ... press conference at Capital Pharmacy and,Medical Equipment urging ... ensure S.1951, the Fair Medicaid Drug Payment Act ... a vote before they adjourn this year.,The bill ...
... ready to attend,holiday parties, it,s time for parents to ... alcohol. Teens are constantly exercising their,independence and individuality, and ... chances are your teens will be too., Even ... guarantees.,According to a study last year by The National ...
... busiest shopping time of the year. In fact, more than ... this year according to a survey by the National Retail ... to the shopping trends. , One such economist, Dr. ... author of The Personality Continuum and Consumer Behavior, has taken ...
... Medical research has revealed much about cancer prevention, but ... acting on it" Today, at the American Association ... in Cancer Prevention Research, being held from December 5 ... of how best to translate cancer prevention science into ...
Other Medicine News:Health News:PET and bioluminescent imaging aid evaluation of stem cells' potential for new ways to treat disease 2Health News:PET and bioluminescent imaging aid evaluation of stem cells' potential for new ways to treat disease 3Health News:University of British Columbia Research Shows Health Benefits of GameBike (TM) 2Health News:Kentucky Pharmacists Urge Senator McConnell to Put Patients First 2Health News:Kentucky Pharmacists Urge Senator McConnell to Put Patients First 3Health News:This Holiday Season, Teach Your Kids the Science of How Drinking Alcohol Can Hurt Them 2Health News:This Holiday Season, Teach Your Kids the Science of How Drinking Alcohol Can Hurt Them 3Health News:Public health and cancer prevention: Success and future challenges in cancer policy 2Health News:Public health and cancer prevention: Success and future challenges in cancer policy 3Health News:Public health and cancer prevention: Success and future challenges in cancer policy 4Health News:Public health and cancer prevention: Success and future challenges in cancer policy 5Health News:Public health and cancer prevention: Success and future challenges in cancer policy 6Health News:Public health and cancer prevention: Success and future challenges in cancer policy 7
Hypervisor III Central Monitoring System...
... Central Monitoring System combines Invivo's AutoNet™ ... central monitoring and clinical information system ... monitoring features, including alarms, full disclosure ... connecting your patient to a bedside ...
The Panorama Central Station includes bi-directional communication with Datascope bedside monitors, optional 72 hours of disclosure and a touch screen user interface....
... List Editor) Multi-Channel Infusion System brings a ... instrument combines three independent infusion channels with ... unparalleled small size. Now with Advanced Dose ... simplifies the delivery of complex drug regimens. ...
Medicine Products: